Calcium gluconate
( DrugBank: Calcium, Calcium gluconate / KEGG DRUG: Calcium gluconate )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 214 | Pulmonary atresia with ventricular septum defect | 1 |
| 215 | Tetralogy of Fallot | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 235 | Hypoparathyroidism | 1 |
214. Pulmonary atresia with ventricular septum defect
Clinical trials : 3 / Drugs : 5 - (DrugBank : 6) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
215. Tetralogy of Fallot
Clinical trials : 24 / Drugs : 32 - (DrugBank : 17) / Drug target genes : 15 - Drug target pathways : 48
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
235. Hypoparathyroidism
Clinical trials : 100 / Drugs : 103 - (DrugBank : 27) / Drug target genes : 5 - Drug target pathways : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|